Latest News - Page 42 of 42 - Oklahoma Society of Clinical Oncology

Neulasta® (pegfilgrastim) – New NDC

A new administration option for Neulasta® is now available: the Neulasta® Delivery Kit. The Neulasta® Delivery Kit (NDC: 55513-192-01) requires administration by a healthcare provider and is available at the same WAC (wholesale acquisition cost) as the currently available Neulasta® prefilled syringe (NDC:  55513-190-01). Neulasta® is a leukocyte growth factor indicated to decrease the incidence […]

Read More

Right Here At Home, Volume 6, Issue 1

2014 Year in Review By Lane Hooton,COO, Cancer Centers of Southwest Oklahoma

Read More

Important Message Regarding IACS System Access Changes Coming Soon!

The CMS Individual Authorized Access to the CMS Computer Services (IACS) system access will be changing to a new platform called Enterprise Identity Management (EIDM) during the First Quarter of 2015.  Please monitor the Novitas website for additional information on this change that will be forthcoming. This change will affect and impact your business.  Find […]

Read More

LLS’ Complimentary Online Continuing Education

The Leukemia & Lymphoma Society (LLS) offers complimentary online continuing education (CE) activities for healthcare professionals. These activities are certified for registered nurses and social workers.  Current LLS activities are available at the links below. Participate and receive CE credit today! CE credit is available for registered nurses and social workers. Upon successful completion of […]

Read More

2015 Drug Testing Codes

Effective January 1, 2015, Current Procedure Terminology (CPT)codes 80300-80377 were added to replace deleted 2014 drug testing codes.  However, at this time, these new codes will not be recognized by Medicare.  Claims reporting codes 80300-80377 will be returned as unprocessable.    New HCPCs G6030-G6058 should be used to report drug testing services in lieu of the new CPT codes. Please […]

Read More

Oplinc Fast Facts

Act Now To Volunteer For Icd-10 End-To-End Testing In April Watch For Medicare Denials On Modifier 59

Read More

Beware of Products Promising Miracle Weight Loss

FDA has found hundreds of products that are marketed as dietary supplements but actually contain hidden active ingredients (components that make a medicine effective against a specific illness) contained in prescription drugs, unsafe ingredients that were in drugs that have been removed from the market, or compounds that have not been adequately studied in humans.

Read More

Medicare Physician Fee Schedule

2015 Final Rule:Changes to Physician Quality Programs

Read More

Medicare Physician Fee Schedule

2015 Final Rule:Changes to Physician Quality Programs

Read More

Xofigo

Important Coding, Purchasing, and Reimbursement Changes for Xofigo® (radium Ra 223 dichloride) Injection Effective January 1, 2015

Read More